Literature DB >> 7062445

Triamterene and renal stone formation.

D J White, G H Nancollas.   

Abstract

We investigated the influence of triamterene (TA), and its metabolites parahydroxytriamterene (PHTA), and parahydroxytriamterene sulfate (PHTAS) on the nucleation and crystal growth of calcium oxalate monohydrate (COM), in supersaturated solution at 37C using a new constant composition technique. The spontaneous precipitation of COM is preceded by induction periods which decrease with increasing supersaturation. The addition of the triamterene seed materials substantially reduces there delay periods and induces the crystal growth of COM. Specific surface area and scanning electron microscopic results indicate that the seed materials act as sources for the heterogeneous nucleation of COM. In addition, the surface of the more crystalline PHTAS appears to offer sites from which COM crystals can develop as well formed rosettes. This evidence suggests that in addition to triamterene renal stone formation, TA and its metabolites may catalyze the precipitation of other stone forming minerals with which urines may be supersaturated.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7062445     DOI: 10.1016/s0022-5347(17)53919-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  Does triamterene cause renal calculi?

Authors:  R G Woolfson; M A Mansell
Journal:  BMJ       Date:  1991-11-16

2.  Triamterene and renal stone formation: the influence of triamterene and triamterene stones on calcium oxalate crystallization.

Authors:  D J White; G H Nancollas
Journal:  Calcif Tissue Int       Date:  1987-02       Impact factor: 4.333

Review 3.  Drug-induced renal calculi: epidemiology, prevention and management.

Authors:  Michel Daudon; Paul Jungers
Journal:  Drugs       Date:  2004       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.